The epidemiology of Budd–Chiari syndrome in France
Epidemiological data is lacking on primary Budd–Chiari syndrome (BCS) in France. Two approaches were used: (1) A nationwide survey in specialized liver units for French adults. (2) A query of the French database of discharge diagnoses screening to identify incident cases in adults. BCS associated wi...
Gespeichert in:
Veröffentlicht in: | Digestive and liver disease 2018-09, Vol.50 (9), p.931-937 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Epidemiological data is lacking on primary Budd–Chiari syndrome (BCS) in France.
Two approaches were used:
(1) A nationwide survey in specialized liver units for French adults.
(2) A query of the French database of discharge diagnoses screening to identify incident cases in adults. BCS associated with cancer, alcoholic/viral cirrhosis, or occurring after liver transplantation were classified as secondary.
Approach (1) 178 primary BCS were identified (prevalence 4.04 per million inhabitants (pmi)), of which 30 were incident (incidence 0.68 pmi). Mean age was 40 ± 14 yrs. Risk factors included myeloproliferative neoplasms (MPN) (48%), oral contraceptives (35%) and factor V Leiden (16%). None were identified in 21% of patients, ≥2 risk factors in 25%. BMI was higher in the group without any risk factor (25.7 kg/m2 vs 23.7 kg/m2, p |
---|---|
ISSN: | 1590-8658 1878-3562 |
DOI: | 10.1016/j.dld.2018.04.004 |